MHC-E-restricted CD8+ T cells target Hepatitis B virus-infected human hepatocytes

Currently 247 million people are living with chronic HBV infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the endogenous HBV-specific T cell response in CHB patients have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol
Main Authors: Burwitz, Benjamin J., Hashiguchi, Patrick K., Mansouri, Mandana, Meyer, Christine, Gilbride, Roxanne M., Biswas, Sreya, Womack, Jennie L., Reed, Jason S., Wu, Helen L., Axthelm, Michael K., Hansen, Scott G., Picker, Louis J., Früh, Klaus, Sacha, Jonah B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109620/
https://ncbi.nlm.nih.gov/pubmed/32161099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1900795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados